Pneumeric, Inc. Partners with JP Pharma for Capnospot® Distribution in Brazil

Pneumeric, Inc. has signed a distribution agreement with JP Pharma to provide the Capnospot® Tension Pneumothorax Decompression Indicator in Brazil. The device aids emergency personnel by offering visual confirmation of correct needle placement. Both companies express confidence in the partnership’s potential for improving pre-hospital care.

Pneumeric, Inc. has forged a distribution agreement with JP Pharma, ensuring that the life-saving Capnospot® Tension Pneumothorax Decompression Indicator reaches police, military, and medical emergency responders across Brazil. This collaboration aims to provide these vital services with an innovative device that visually confirms the correct needle placement during critical procedures.

The Capnospot® device enables a quick, color change confirmation, which allows healthcare providers to efficiently administer necessary life-saving treatments. JP Pharma, a leading tactical medical supplier in Latin America, recognized the significance of integrating the Capnospot® device into its offerings, enhancing its portfolio of advanced medical technologies.

Bruno Tavora, JP Pharma’s Chief Operating Officer, expressed enthusiasm for this partnership, highlighting that their shared commitment to improving pre-hospital care will contribute to saving lives in Brazil. Similarly, Deon Miller, Chief Commercial Officer of Pneumeric, Inc., notes optimism about the mutually beneficial nature of this collaboration in advancing the distribution of this innovative technology.

The Capnospot® device is designed to enhance the efficacy and precision of tension pneumothorax decompression procedures. By offering real-time confirmation of successful interventions, it significantly elevates the standard of patient care and assists first responders in critical situations.

Pneumeric, Inc. was established in 2021 with a mission to improve the quality of tension pneumothorax management and to minimize treatment failures. With its FDA clearance and two existing patents, Pneumeric is dedicated to advancing the capabilities of emergency medical response. For further information on Capnospot® and Pneumeric, prospective clients may visit their official website.

Founded in 2008, JP Pharma consists of experienced professionals from health and military backgrounds, focusing on providing Brazil with premier medical products. Their efforts are fueled by a commitment to secure strategic partnerships to deliver world-class medical equipment.

In summary, Pneumeric, Inc. has successfully partnered with JP Pharma to distribute the Capnospot® Tension Pneumothorax Decompression Indicator in Brazil. This collaboration emphasizes innovation in emergency medical care, enhancing the capacity of responders. With a focus on life-saving technology, both companies aim to elevate the standard of pre-hospital care while significantly impacting patient outcomes.

Original Source: www.prweb.com